Hyperglycemia-induced ROS (reactive oxygen species) overproduction is a major contributor to chronic low-grade inflammation, the activated NLRP3 inflammasome becoming a key in the pathogenesis of metabolic disturbances characteristic for CMS [32,34]. The gene discussed is NLRP3; the disease is congenital myasthenic syndrome.